DR. SINGH DIRECT PRIMARY CARE

Primary care as it should be
Linkedin-in Youtube

Primary care as it should be

Dr. SINGH

Direct Primary Care

Linkedin-in Youtube

Semaglutide & Tirezepatide Weight loss porgram

TIRZEPATIDE NOT BEING OFFERED RIGHT NOW TAKEN OFF SHORTAGE LIST 10/02/24 BY FDA

Get started on your weight loss journey with our introductory package!

This 8-week program includes:
  • An initial consultation with a physician via telemedicine to develop a personalized plan and set achievable goals
  • An evaluation of your options, including Phentermine, Semaglutide, and Tirzepatide
  • A compound pharmacy medication with an average monthly cost ranging from $170-610, depending on the formulation
  • Two months of medical weight loss support and direct access to your physician for any dose changes or side effect management
  • Convenient prescription submission to the pharmacy

The total cost of this initial medication consultation is $125 every 2 months and $65 initial set up fee

Ongoing support package

Every 8 Weeks

  • Ongoing medication costs averaging $170-610 per month for 2 months
  • Re-issuance of prescription
  • Continuous assistance for your weight loss journey
  • Customized plans for reaching your desired weight
  • Safe and thorough monitoring, including lab tests if necessary.
  • Continued Support Package: Every 8-12 Weeks
  • Every 8 Weeks: $125 after the initial 8 weeks (which is $185 promotional value)
Sign up
Medication Prices

Semaglutide Information (GLP-1)

Benefits
  • Reduced appetite and Urges
  • Weight Reduction
  • Potential weight loss of 15-25 pounds within 2 months, and up to 25-50 pounds or more in 4 months
  • Compounded formulas that may relieve side effects such as nausea
  • Weekly injections
  • Option to repeat the program as many times as you wish
Common Side Effects
  • Nausea
  • Constipation
  • Heartburn
Risk of Thyroid c-cell Tumors
Individuals or family members diagnosed with Multiple Endocrine Neoplasia Syndrome Type 2 or medullary thyroid cancer should not take Semaglutide
Information
Semaglutide stimulates a natural hormone that impacts hunger and fullness sensations, leading to reduced cravings and weight loss. During a clinical trial involving 2,000 individuals from 16 different countries, those who received weekly injections of Semaglutide lost an average of 15% of their body weight, compared to just a 3% loss in the placebo group.
Prices
  • See pricing chart
Sign Up

Tirzepatide Information (GLP-1 + GIP) 

NOT BEING OFFERED RIGHT NOW TAKEN OFF SHORTAGE LIST 10/02/24 BY FDA

Benefits
  • Reduce appetite and cravings
  • leading to weight loss
  • The results from clinical trials have demonstrated a significant reduction in weight, ranging from 15% to 30%, based on the dose prescribed.
  • To minimize the occurrence of side effects, such as nausea, the medication is compounded with specific formulas.
  • The injections are administered once a week
  • Can repeat the program as many times as necessary to achieve desired weight loss goals
Common Side Effects
  • Nausea
  • Constipation
  • Indigestion
Risk of Thyroid c-cell Tumors
Individuals or family members diagnosed with Multiple Endocrine Neoplasia Syndrome Type 2 or medullary thyroid cancer should not take Semaglutide
Information
Tirzepatide is a medication that targets two receptors in the brain responsible for regulating food intake and appetite. It works by combining the actions of glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). In a clinical trial involving 2,539 adults, the use of Tirzepatide resulted in weight loss ranging from 15% to 35% compared to the placebo group.
Prices
  • See pricing chart
Sign Up